David Sans
Corporate Officer/Principal en CALIDI BIOTHERAPEUTICS, INC. .
Fortuna: 10 347 $ al 31/03/2024
Perfil
David Sans is currently the Chief Corporate Development at Calidi Biotherapeutics, Inc. Prior to this, he worked as the Head of Business Development at ImClone LLC.
Mr. Sans holds a doctorate degree from Ramon Llull University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/09/2023 | 18 314 ( 0.05% ) | 10 347 $ | 31/03/2024 |
Cargos activos de David Sans
| Empresas | Cargo | Inicio |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de David Sans.
| Empresas | Cargo | Fin |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Director/Board Member | - |
Formación de David Sans.
| Ramon Llull University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- David Sans
